Evidence map›Paper›PMID 21457539›Full record

Trial reportBMC infectious diseases2011

A longitudinal study of allergy and intestinal helminth infections in semi urban and rural areas of Flores, Indonesia (ImmunoSPIN Study).

Firdaus Hamid, Aprilianto E Wiria, Linda J Wammes, Maria Mm Kaisar, Bertrand Lell, Iwan Ariawan, Hae Won Uh, Heri Wibowo, Yenny Djuardi, Sitti Wahyuni and 7 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Helminth therapy (worms) for allergic rhinitis.The Cochrane database of systematic reviews · 2012
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Glycoconjugates in host-helminth interactions.Frontiers in immunology · 2013
    Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Firdaus HamidDepartment of Microbiology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Aprilianto E Wiria
Linda J Wammes
Maria Mm Kaisar
Bertrand Lell
Iwan Ariawan
Hae Won Uh
Heri Wibowo
Yenny Djuardi
Sitti Wahyuni
Robert Schot
Jaco J Verweij
Ronald van Ree
Linda May
Erliyani Sartono
Maria Yazdanbakhsh
Taniawati Supali
Leiden University Medical Center · NLUniversity of Indonesia · IDHasanuddin University · IDAcademic Medical Center · NLUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of asthma and atopic disease has been reported to be low in low income countries, however helminth infections are likely to be high among these communities. The question of whether helminth infections play a role in allergic diseases can best be addressed by intervention studies. None of the studies so far have been based on a large scale placebo-controlled trial. METHOD/

designThis study was designed to assess how intestinal helminth infections can influence the immune response and atopic and allergic disorders in children in Indonesia. The relations between allergic outcomes and infection and lifestyle factors will be addressed. This study was set up among school-age children in semi urban and rural areas, located in Ende District of Flores Island, Indonesia. A randomized placebo-controlled anthelmintic treatment trial to elucidate the impact of helminth infections on the prevalence of skin prick test (SPT) reactivity and symptoms of allergic diseases will be performed. The children living in these semi-urban and rural areas will be assessed for SPT to allergens before and after 1 and 2 years of treatment as the primary outcome of the study; the secondary outcome is symptoms (asthma and atopic dermatitis); while the tertiary outcome is immune responses (both antibody levels to allergens and cellular immune responses). DISCUSSION: The study will provide information on the influence of helminth infections and anthelmintic treatment on immune response, atopy and allergic disorders.

trial registrationCurrent Controlled Trials ISRCTN: ISRCTN83830814.

Indexed as

AlbendazoleAllergensAnimalsAnthelminticsAsthmaChildChild, PreschoolDermatitis, AtopicDouble-Blind MethodFemaleHelminthiasisHelminthsHumansHypersensitivity, ImmediateIndonesiaIntestinal Diseases, ParasiticAlbendazoleAllergensAnthelmintics

Identifiers

PMID21457539
PMCPMC3090332
OpenAlexW2004035409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.